IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q1 2026 Holdings

Filed 2026-05-14 | 7 holdings | $4.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr Gold TR(GLD)GOLD SHS78463V107$3.3M7,62381.5%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$348.3K7278.7%
Kyverna Therapeutics Inc(KYTX)COM501976104$162.0K18,7734.0%
Lexeo Therapeutics Inc(LXEO)COM52886X107$80.0K13,9432.0%
X4 Pharmaceuticals Inc(XFOR)COM NEW98420X202$64.2K15,5571.6%
Inhibikase Therapeutics Inc(IKT)COM NEW45719W205$47.8K28,4531.2%
ALX Oncology Hldgs Inc(ALXO)COM00166B105$42.0K20,9461.0%